Akoya Biosciences Inc.

NASDAQ: AKYA · Real-Time Price · USD
1.25
-0.05 (-3.85%)
At close: May 23, 2025, 10:58 AM

Akoya Biosciences Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Product Revenue 53.03M 67.41M 57.65M 44.48M
Product Revenue Growth -21.34% +16.93% +29.62% n/a
Service and other Revenue 28.64M 29.22M 17.21M 10.44M
Service and other Revenue Growth -1.98% +69.81% +64.84% n/a
Consumables Revenue 28.26M 24.13M 18.38M 14.3M
Consumables Revenue Growth +17.09% +31.31% +28.54% n/a
Instruments Revenue 23.83M 42.09M 38.63M 28.69M
Instruments Revenue Growth -43.39% +8.96% +34.65% n/a
Service And Other Revenue 17.28M 18.93M 636K 1.49M
Service And Other Revenue Growth -8.73% +2876.26% -57.23% n/a
Standalone software products Revenue 940K 1.18M n/a n/a
Standalone software products Revenue Growth -20.41% n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 17.58M 15.69M 14.67M 19.09M 19.86M 18.9M 19.02M 22.71M 21.76M 20.95M 19.92M 20.59M 18.19M 19.05M 13.72M 10.07M 8.18M 6.82M 5.71M 5.11M 6.35M
Selling, General, and Administrative Revenue Growth +12.06% +6.92% -23.16% -3.87% +5.11% -0.63% -16.25% +4.37% +3.87% +5.15% -3.24% +13.18% -4.48% +38.77% +36.35% +23.07% +20.00% +19.33% +11.89% -19.59% n/a
Research and Development Revenue 5.56M 4.43M 4.47M 5.29M 5.55M 4.67M 5.17M 6.27M 5.77M 6.43M 5.47M 5.6M 5.71M 5.56M 4M 2.95M 3.19M 2.53M 2.28M 2.42M 2.37M
Research and Development Revenue Growth +25.47% -1.01% -15.39% -4.79% +18.93% -9.72% -17.54% +8.66% -10.26% +17.69% -2.36% -2.03% +2.71% +39.11% +35.70% -7.68% +26.07% +11.10% -5.83% +2.02% n/a